Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster logo

Canadian Cancer Society: Breakthrough Team Grants – Transforming the Future of Metastatic Cancer

Research Admin Offices:

  • HRS

Funding Type:

Grant

Opportunity Type:

  • Grant

Value:

Up to $7,500,000 over five years.

Disciplines:

  • Health Sciences

Sponsors:

  • Canadian Cancer Society

Deadlines:

Internal Deadline:

June 13, 2024

Sponsor Deadline:

October 15, 2024

Additional Dates:

  • Informational and Networking Workshop (mandatory) - May 9, 2024
  • LOI HRS Due Date - June 13, 2024
  • LOI: Sponsor Due Date - June 27, 2024
  • Application Due Date (by invitation) - October 15, 2024

Description:

This opportunity supports team grants on two themes:

Develop a better understanding of the biology of and mechanisms associated with cancer cell dormancy

  • Investigates different models of dormancy such as angiogenic, immune-mediated, and cellular dormancy
  • Delineates the mechanisms behind why certain types/subtypes of cancer are more prone to dormancy (and hence, metastases)
  • Explores the individual factors (genetic, molecular, etc.) that lead some to develop metastatic disease while others do not
  • Develops (and utilizes) new, physiologically relevant model systems that accurately represent dormancy in human cancers
  • Could result in interventions that can prevent the onset of metastatic disease

Support people living with advanced or metastatic disease throughout the course of their disease

  • Examines interdisciplinary prevention/management of symptoms and chronic conditions (including non-pharmacological management)
  • Seeks to provide improved psychosocial support
  • Seeks to develop integrated and appropriate palliative care
  • Improves support for caregivers
  • Considers longitudinal studies to provide a clearer picture of the unique needs of people living with long-term metastatic disease (particularly as they relate to patient-reported outcomes), or that could identify factors associated with longer-term survival of people diagnosed with metastatic disease
  • Seeks to better coordinate and deliver complex care
  • Considers equitable access to anticipated project outcomes from the outset

Resources:

Additional Details.

Contact:

If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.